Drug
AZD 1480 clinical trials
Also written AZD1480.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Development codes
- AZD1480
- 2
Studies by the year they started
3 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2010 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Related medicines
As reviewed, each with the page that says it.
- One of Janus Kinase Inhibitors source
- One of Protein Kinase Inhibitors source
- One of Tyrosine Kinase Inhibitors source
Studies
Open first, then newest update. How each study uses AZD 1480 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative DiseasesCompletedPhase 1AstraZenecaNCT00910728Written as AZD1480
- Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid TumoursTerminatedPhase 1AstraZenecaNCT01112397Written as AZD1480
- A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.TerminatedPhase 1AstraZenecaNCT01219543Written as AZD1480 Daily
Codes
What other systems call AZD 1480 · ClinicalTrials.gg INT005537
- UNII (FDA) KL2Z2TLF01AZD-1480Confirmed FDA, Wikidata
- Wikidata Q27074711azd-1480Confirmed FDA, Wikidata
- DrugBank DB12588One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | KL2Z2TLF01 | AZD-1480 | Confirmed FDA, Wikidata |
| Wikidata | Q27074711 | azd-1480 | Confirmed FDA, Wikidata |
| DrugBank | DB12588 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.